Here we provide you with HIV & TB drug resistance information in the form of reports, clinical cases, tweets and publications.
In this new section of the bioafrica.net website, physicians, researchers and public health officials can learn about our drug resistance work and its application to the management of patients failing ARVs and anti-TB therapies.
By Justen Manasa - 2013-08-21
SATuRN 2013 report
By Dean Solomon and Tulio de Oliveira - 2013-08-01
SATuRN 2013 report
Major data analysis determines the trends of HIV-1 drug resistance mutations in South Africa.
By Tulio de Oliveira - 2013-07-01
SATuRN report 2013
By Tulio de Oliveira, Justen Manasa, Richard Lessells - 2013-03-16
SATuRN 2013 report
Bioafrica.net & SATuRN webpages received 186,746 visits in the past 12 months!
By Tulio de Oliveira - 2013-02-26
SATuRN 2013 report
Clinical Case Study: The Diagnosis and Management of First-line Antiretroviral Treatment Failure
By Theresa Rossouw, Tulio de Oliveira & Richard Lessells - 2013-01-16
SATuRN 2012 report
By Dominique Goedhals & Cloete van Vuuren - 2012-07-10
SATuRN 2012 report
Moderate to high levels of pre-treatment HIV drug resistance in KwaZulu-Natal Province, South Africa. AIDS Research and Human Retroviruses (2019), I.F.:4
Early detection of emergent extensively drug resistant tuberculosis (XDR-TB) by flow cytometry-based phenotyping and whole genome sequencing. Antimicrob Agents Chemother. (2019), I.F.:4.476
Spatial structure of depression in South Africa: A longitudinal panel survey of a nationally representative sample of households. Scientific Reports (2019), I.F.:4.122
Sociobehavioral and community predictors of unsuppressed HIV viral load: multilevel results from a hyperendemic rural South African population. AIDS (2019), I.F.:4.914
Genome Detective: An Automated System for Virus Identification from High-throughput sequencing data.. Bioinformatics (2018), I.F.:7.307
High percentage of undiagnosed HIV cases within a hyperendemic South African community: a population-based study. J Epidemiol Community Health (2018), I.F.:3.608
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV (2018), I.F.:9.842
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. Lancet ID (2018), I.F.:19.864
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest. (2018), I.F.:12.784
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells. Science (2018), I.F.:37.205